Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

MHRA0033319_044 - Application for Kryobulin Dried Factor VIII Heat Treated

Published on: 10 July, 2023

MHRA0033320_006 - Application for Kryobulin Dried Factor VIII Heat Treated

Published on: 10 July, 2023

MHRA0033320_007 - Precautions and Warnings

Published on: 10 July, 2023

MHRA0033320_044 - Application for Kryobulin Dried Factor VIII Heat Treated - 01 Jul 1986

Published on: 10 July, 2023

MHRA0033321_022 - Kryobulin Dried Factor VIII Fraction - 01 Mar 1985

Published on: 10 July, 2023

MHRA0033321_085 - Application for Kryobulin - 11 Nov 1976

Published on: 10 July, 2023

MHRA0033321_102 - Letter from D S Dane to N Berry - 18 Jul 1975

Published on: 10 July, 2023

MHRA0033321_105 - Letter from Norman Berry to D S Dane - 17 Jul 1975

Published on: 10 July, 2023

MHRA0033321_107 - Note from J A Holgate to Dr Andrews - 15 Jul 1975

Published on: 10 July, 2023

MHRA0033321_108 - Letter from D S Dane to N Berry - 14 Jul 1975

Published on: 10 July, 2023

MHRA0033322_001 - Letter from Managing Director Serological Products Limited to D A Winfield - 02 Oct 1974

Published on: 10 July, 2023

MHRA0033322_003 - Letter from Managing Director Serological Products Limited to D P Thomas - 12 Sep 1974

Published on: 10 July, 2023

MHRA0033322_057 - Memorandum from Dr Maycock - 04 Jan 1973

Published on: 10 July, 2023

MHRA0033323_003 - Letter from D P Thomas to N Berry - 22 Dec 1972

Published on: 10 July, 2023

MHRA0033325_002 - Application for Kryobulin Human Antihaemophilic Fraction - 01 Dec 1972

Published on: 10 July, 2023

MHRA0033382_007 - Memorandum from G Silverster to C Grier - 11 Jan 1990

Published on: 10 July, 2023

MHRA0033386_009 - Letter from J P Betts to J Bewley - 26 Jan 1990

Published on: 10 July, 2023

MHRA0033386_019 - Letter from J Sloggem to Mr Franks and Mrs Rabindran - 23 Nov 1989

Published on: 10 July, 2023

MHRA0033386_023 - Letter from J P Betts to Medicines Control Agency - 25 Oct 1989

Published on: 10 July, 2023

MHRA0033387_010 - Letter from J P Betts to Variations Section - 04 Nov 1986

Published on: 10 July, 2023

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 3229
  • Page 3230
  • Page 3231
  • Page 3232
  • Current page 3233
  • Page 3234
  • Page 3235
  • Page 3236
  • Page 3237
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.